Andrew Hirsch

Insider Reports History

Entity
Individual
Location
C/O Bind Therapeutics, Inc., 325 Vassar St, Cambridge, MA
Signature
/s/ Jolie M. Siegel, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Hirsch:

Stock Role Class Num Shares Value Price $ Report Date Ownership
C4 Therapeutics, Inc. President & CEO, Director Common Stock 222K $1.34M $6.04 Nov 7, 2024 Direct
C4 Therapeutics, Inc. President & CEO, Director Performance Restricted Stock Units 35K $211K $6.04 Nov 7, 2024 Direct
C4 Therapeutics, Inc. President & CEO, Director Stock Option (Right to Buy) 466K Feb 14, 2024 Direct
Editas Medicine, Inc. Director Stock Option (right to buy) 25K May 30, 2024 Direct

Insider Reports Filed by Andrew Hirsch

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CCCC C4 Therapeutics, Inc. Nov 7, 2024 3 -$33.5K 4 Nov 12, 2024 President & CEO, Director
CCCC C4 Therapeutics, Inc. Sep 16, 2024 3 -$21.2K 4 Sep 17, 2024 President & CEO, Director
EDIT Editas Medicine, Inc. May 30, 2024 1 $0 4 Jun 3, 2024 Director
CCCC C4 Therapeutics, Inc. Feb 15, 2024 1 -$51.8K 4 Feb 15, 2024 President & CEO, Director
CCCC C4 Therapeutics, Inc. Feb 14, 2024 2 $0 4 Feb 15, 2024 President & CEO, Director
CCCC C4 Therapeutics, Inc. Sep 18, 2023 1 $0 4 Sep 19, 2023 President & CEO, Director
CCCC C4 Therapeutics, Inc. Aug 30, 2023 3 -$6.46K 4 Aug 31, 2023 President & CEO, Director
EDIT Editas Medicine, Inc. Jun 1, 2023 1 $0 4 Jun 5, 2023 Director
CCCC C4 Therapeutics, Inc. Feb 15, 2023 2 $0 4 Feb 15, 2023 President & CEO, Director
CCCC C4 Therapeutics, Inc. Jan 30, 2023 3 -$33.6K 4 Feb 1, 2023 President & CEO, Director
EDIT Editas Medicine, Inc. Jun 9, 2022 1 $0 4 Jun 13, 2022 Director
CCCC C4 Therapeutics, Inc. May 26, 2022 1 -$25.8K 4/A Jun 14, 2022 President & CEO, Director
CCCC C4 Therapeutics, Inc. May 25, 2022 2 $0 4 May 27, 2022 President & CEO, Director
CCCC C4 Therapeutics, Inc. Apr 12, 2022 1 $84K 4 Apr 12, 2022 President & CEO, Director
CCCC C4 Therapeutics, Inc. Feb 23, 2022 1 $0 4 Feb 23, 2022 President & CEO, Director
EDIT Editas Medicine, Inc. Jun 3, 2021 1 $0 4 Jun 7, 2021 Director